Health knowledge and news provided by doctors.

Ads by Google


FDA Approves VYVANSE For ADHD Treatment

Shire plc has received approval from FDA for VYVANSE (lisdexamfetamine dimesylate), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults. VYVANSE, introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years, is now the first and only once-daily prodrug stimulant approved to treat adults with ADHD. In its first eight months of availability, more than one million VYVANSE prescriptions have been filled.


ADHD Children Need To Be Tested For Heart Before Treatment

The stimulant drugs, used for ADHD treatment, while not much significant, are important to monitor for children with ADHD and certain heart conditions. This is why ADHD children should receive an electrocardiogram (ECG) to rule out heart abnormalities before beginning ADHD treatment with stimulant drugs.